Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Premium
Alternative Insight and Premium Journalism
Latest Articles
For Members Only
Valiant Fattens up on Eli Lilly Shares
Stephen Taub
November 2, 2023
For Members Only
Greenlight Adds to Huge Gains
Stephen Taub
November 1, 2023
For Members Only
D1, Other Hedgies Eye Biopharma IPO
October 31, 2023
For Members Only
Groupon’s Next Deal
Stephen Taub
October 30, 2023
For Members Only
Hedge Funds on Amazon Alert
Stephen Taub
October 26, 2023
For Members Only
Credit Funds Post Third-Quarter Gains
October 25, 2023
For Members Only
Hedgies Eye Biopharma IPO
Stephen Taub
October 24, 2023
For Members Only
This Might Be the Most Volatile Hedge Fund
Stephen Taub
October 23, 2023
For Members Only
Singh’s Axon Continues to Soar
Stephen Taub
October 19, 2023
For Members Only
Bridgewater Moves Into the Black
Stephen Taub
October 18, 2023
For Members Only
A Tiger Grandcub Goes Activist
Stephen Taub
October 17, 2023
For Members Only
EcoR1 Makes a Timely Bet
Stephen Taub
October 16, 2023
For Members Only
The Tiger Crowd Sagged in September
Stephen Taub
October 12, 2023
For Members Only
Amid a Rough Year for Life Sciences, Cormorant Delivers Healthy Returns
Stephen Taub
October 11, 2023
For Members Only
Why Most of AQR’s Largest Strategies Rose Sharply in September
Stephen Taub
October 10, 2023
For Members Only
Third Point Doubles Its Short Positions
Stephen Taub
October 9, 2023
For Members Only
Hedge Funds Sharply Curtail Private Investments
Stephen Taub
October 4, 2023
For Members Only
Hedge Fund Faves Outperform in 3Q
Stephen Taub
October 3, 2023
More Articles